Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001628280-23-042820

Director acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ling Gabriel Director 2023-12-26 Grant or award +40,000 69,057 D
Loading xslF345X05/wk-form4_1703801773.xml…